Xiubao Ren

31PUBLICATIONS
31CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jun 02, 2026
Low expression of ONECUT2 governs the POU6F2-beta-catenin axis to modulate cancer stemness and drives the CCL28-dependent pathway for macrophage polarization in breast cancer.

|Mar 04, 2026
Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2-Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial.

Tianshu Liu, Suxia Luo, Xianglin Yuan

|Dec 24, 2025
The predictive value of neutrophil extracellular trap-related risk score in prognosis and tertiary lymphoid structure features of lung adenocarcinoma patients.

Zhe Wang, Yingying Wang, Jiahui Zhou

|Dec 19, 2025
Progenitor-predominant exhaustion in cytokine-induced killers reveals TIM-3 as a superior target for enhancing cytokine-induced killer cytotoxicity.

Jian Wang, Qin Wang, Jiahui Zhou

|Dec 01, 2025
A prospective, multicenter, comprehensive genomic profile signature study in patients with EGFR-mutant advanced non-small cell lung cancer at the first-line treatment failure of osimertinib.

Yuankai Shi, Dongqing Lv, Weineng Feng

|Aug 14, 2025
Causal relationships between immunophenotypes, plasma metabolites, and pancreatic cancer: a mediation Mendelian randomization study.

Jiawei Liu, Jian Zhou, Hongyu Bie

Pageof 6

Frequent Collaborators

5 joint publications

Feng Wei

4 joint publications

Qian Sun

3 joint publications

Lili Yang

2 joint publications

Jun Liang